Published in Biochem Med on August 01, 1977
Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Arch Gen Psychiatry (1997) 2.08
Saving costs and enhancing patient care: a solution's solution. J Ophthalmic Nurs Technol (1991) 1.93
Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction. Eur J Clin Pharmacol (1983) 1.38
Hypothyroidism and hyperparathyroidism associated with lithium. Lancet (1973) 1.35
5-Bromo-2-deoxyuridine regulates invasiveness and expression of integrins and matrix-degrading proteinases in a differentiated hamster melanoma cell. J Cell Sci (1993) 1.25
Withdrawal and limitation of life support in paediatric intensive care. Arch Dis Child (1999) 1.12
Learning is improved by a soybean oil diet in rats. Life Sci (1986) 1.09
The rewarding properties of neuropeptide Y in perifornical hypothalamus vs. nucleus accumbens. Peptides (2000) 1.00
Effects of dietary fat on pain threshold, thermoregulation and motor activity in rats. Pharmacol Biochem Behav (1986) 0.98
Life events precipitating mania. Br J Psychiatry (1983) 0.95
The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry (1997) 0.93
Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry (1994) 0.93
Depressive disorders and HLA: a gene on chromosome 6 that can affect behavior. N Engl J Med (1981) 0.92
Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain (1978) 0.92
Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. J Affect Disord (1999) 0.91
Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Res (1999) 0.91
High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry (1997) 0.91
Body image disturbances in anorexia nervosa and obesity. Psychosom Med (1976) 0.90
Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem (1993) 0.90
Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. Clin Chim Acta (1982) 0.89
Hypothalamic-pituitary function in anorexia nervosa. Arch Gen Psychiatry (1975) 0.89
Synthesis of some 3-indenealkylamines. Comparison of the biological activity of 3-indenealkylamines and 3-benzo[b]thiophenealkylamines with their tryptamine isosteres. J Med Chem (1967) 0.89
Blindness and menarche. Life Sci (1970) 0.88
Effect of carbidopa on prolactin, growth hormone and cortisol secretion in man. J Clin Endocrinol Metab (1976) 0.88
Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient. Brain Res (2001) 0.88
Psychopharmacology. Yesterday, today and tomorrow: a point of view. Can Psychiatr Assoc J (1973) 0.87
The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem (1996) 0.86
Incidence of acute respiratory distress syndrome: a comparison of two definitions. Arch Dis Child (1998) 0.86
Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine. Peptides (1998) 0.86
Treatment of anorexia nervosa using operant conditioning techniques. J Nerv Ment Dis (1973) 0.85
Brain and behavioral effects of dietary n-3 deficiency in mice: a three generational study. Dev Psychobiol (1994) 0.85
Brown adipose tissue of rats with obesity-inducing ventromedial hypothalamic lesions. Am J Physiol (1982) 0.84
Paediatric intensive care in Kuala Lumpur, Malaysia: a developing subspecialty. J Trop Pediatr (1999) 0.84
Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levels. Pharmacogenomics J (2004) 0.84
Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Clinical observations. Arch Gen Psychiatry (1982) 0.83
Serotonin receptors in hippocampus and frontal cortex. Eur J Pharmacol (1980) 0.83
In vitro and ex vivo effects of antidepressants on rat brain membrane-bound phosphatidylinositol synthetase activity. Neurochem Res (1988) 0.83
Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition. J Pharmacol Exp Ther (1976) 0.83
A longitudinal investigation of lithium as a prophylactic agent for recurrent depressions. Can Psychiatr Assoc J (1970) 0.83
Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Mol Psychiatry (2001) 0.83
Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin. J Clin Invest (1984) 0.83
Whole-body metabolism varies across the estrous cycle in Sprague-Dawley rats. Physiol Behav (2001) 0.82
Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am J Psychiatry (1994) 0.82
A comparison of the effects of the 5-HT1 agonists TFMPP and RU 24969 on feeding following peripheral or medial hypothalamic injection. Brain Res (1992) 0.82
Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats. Synapse (1999) 0.82
Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem (1997) 0.82
Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. Biol Psychiatry (1997) 0.81
Regional hypothalamic differences in neuropeptide Y-induced feeding and energy substrate utilization. Brain Res (1996) 0.81
Lack of diet-induced thermogenesis in brown adipose tissue of obese medial hypothalamic-lesioned rats. Physiol Behav (1985) 0.81
Body awareness in anorexia nervosa: disturbances in "body image" and "satiety". Psychosom Med (1978) 0.81
Metergoline potentiates natural feeding and antagonizes the anorectic action of medical hypothalamic 5-hydroxytryptamine. Pharmacol Biochem Behav (1996) 0.81
Altered TRPC7 gene expression in bipolar-I disorder. Biol Psychiatry (2001) 0.81
Is there a non-dopaminergic nigrostriatal pathway? Neuroscience (1981) 0.81
Life threatening pancreatitis following varicella vaccination: cause, association or co-incidence? Med J Malaysia (2000) 0.81
Controlled exercise elevates plasma but not urinary MHPG and VMA. Psychiatry Res (1981) 0.80
Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J Neurochem (1999) 0.80
Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder. Brain Res (1991) 0.80
Evidence for homogeneity of major depression and bipolar affective disorder. J Psychiatr Res (1987) 0.80
Differential binding of 3H-imipramine and 3H-mianserin in rat cerebral cortex. Life Sci (1981) 0.80
Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol. Can J Physiol Pharmacol (1979) 0.80
The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma. Clin Pharmacol Ther (1984) 0.80
Determination of picogram levels of brain serotonin by a simplified liquid chromatographic electrochemical detection assay. Brain Res Bull (1979) 0.80
Graded increases in brain GABA: differential effects on feeding and other behaviours in rats. Behav Brain Res (1988) 0.80
Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum. Am J Psychiatry (1986) 0.80
CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse (1993) 0.80
Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats. Brain Res Bull (1979) 0.79
Centrally administered urocortin 2 decreases gorging on high-fat diet in both diet-induced obesity-prone and -resistant rats. Int J Obes (Lond) (2013) 0.79
Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding. Neuroreport (1997) 0.79
Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus. Peptides (1995) 0.79
5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient. Brain Res (1998) 0.79
Lithium modulation of phosphoinositide signaling system in rat cortex: selective effect on phorbol ester binding. J Neurochem (1993) 0.79
Corticosterone-responsive and -unresponsive metabolic characteristics of adrenalectomized rats. Am J Physiol (1994) 0.79
Formation and clearance of norepinephrine glycol metabolites in mouse brain. J Neurochem (1984) 0.79
Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease. Neurosci Lett (1988) 0.79
Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.79
The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. J Neurochem (2000) 0.79
Quantitative analysis and fatty acid composition of phospholipid constituents in cerebrospinal fluid of various age groups. Clin Chim Acta (1968) 0.79
Rat brain and plasma norepinephrine glycol metabolites determined by gas chromatography-mass fragmentography. J Neurochem (1981) 0.78
Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder. Biol Psychiatry (2000) 0.78
Effects of chronic amitriptyline and desipramine on food intake and body weight in rats. Pharmacol Biochem Behav (1987) 0.78
[3H]inositol 1,4,5-triphosphate binding in human cerebral cortex. Neurosci Lett (1988) 0.78
Lack of effect of chronic antidepressant treatment on Gs and Gi alpha-subunit protein and mRNA levels in the rat cerebral cortex. Neuropsychopharmacology (1996) 0.78
Gas chromatography--mass fragmentographic determination of indole-3-acetic acid in rat brain. J Neurochem (1977) 0.78
Studies on the utility of urinary 3,4-dihydroxyphenylethylene-glycol (DHPG) measurement. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.78
Taming effects of handling on 6-hydroxydopamine induced ratge. Pharmacol Biochem Behav (1975) 0.78
L-Dopa and schizophrenia. Can Psychiatr Assoc J (1976) 0.78
G-protein involvement in central-nervous-system muscarinic-receptor-coupled polyphosphoinositide hydrolysis. Biochem J (1988) 0.78
Bufotenine esters. J Med Chem (1979) 0.78
Lipid composition of human, bovine and sheep pineal glands. J Neurochem (1969) 0.78